Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | PDE5A | O76074 | 4/20 | 0.45 |
| ▸ | PDE4A | P27815 | 3/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.45 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL447310 | 0.82 | ALDH1A1 (0.44) | CYP1A2CYP2C19MAPTPDE5AKDM4E | |
| SCHEMBL16582005 | 0.82 | MEN1 (0.57) | CYP1A2CYP2C9CYP2C19CYP19A1MEN1 | |
| SCHEMBL8487255 | 0.82 | KMT2A (0.39) | CYP1A2MEN1LMNAKMT2AKDM4E | |
| SCHEMBL9703336 | 0.80 | TP53 (0.44) | MEN1LMNAKMT2APDE5AKDM4E | |
| SCHEMBL8166039 | 0.79 | CYP1A2 (0.45) | CYP1A2CYP2C9CYP2C19CYP19A1MEN1 | |
| SCHEMBL10500436 | 0.77 | TP53 (0.33) | CYP1A2CYP2C9CYP2C19CYP19A1PDE5A | |
| SCHEMBL15966958 | 0.77 | KDM4E (0.49) | CYP1A2CYP2C9CYP2C19CYP19A1MEN1 | |
| SCHEMBL2859001 | 0.76 | LMNA (0.62) | CYP1A2CYP2C9CYP2C19MEN1NR1I2 | |
| SCHEMBL9387360 | 0.76 | LMNA (0.62) | CYP1A2CYP2C9CYP2C19MEN1NR1I2 | |
| SCHEMBL2245919 | 0.76 | LMNA (0.62) | CYP1A2CYP2C9CYP2C19MEN1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2753662-B1 | EPOXY FORMULATIONS AND PROCESSES FOR FABRICATION OF RELIEF PATTERNS ON LOW SURFACE ENERGY SUBSTRATES | MICROCHEM CORP (US) | 2020-06-24 | — | — | EP | disclosed |
| US-20150024326-A1 | PHOTOIMAGEABLE COMPOSITIONS AND PROCESSES FOR FABRICATION OF RELIEF PATTERNS ON LOW SURFACE ENERGY SUBSTRATES | KAYAKU ADVANCED MATERIALS, INC. | 2015-01-22 | — | — | US | disclosed |
| US-20140302430-A1 | EPOXY FORMULATIONS AND PROCESSES FOR FABRICATION OF RELIEF PATTERNS ON LOW SURFACE ENERGY SUBSTRATES | MICROCHEM CORP. (US) | 2014-10-09 | — | — | US | disclosed |
| US-7601480-B2 | Photoactive compounds | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2009-10-13 | — | — | US | disclosed |
| US-20080153032-A1 | Photoactive Compounds | MERCK PATENT GMBH (DE) | 2008-06-26 | — | — | US | disclosed |
| WO-2001014460-A1 | A METHOD FOR FORMING POLYMERIC PATTERNS, RELIEF IMAGES AND COLORED POLYMERIC BODIES USING DIGITAL LIGHT PROCESSING TECHNOLOGY | SPECTRA GROUP LIMITED, INC. (US) | 2001-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153032-A1 | Photoactive Compounds | SUN2, CRY2, SCO2 | CYP1A2 2590/4885CYP2C9 868/4885CYP2C19 1063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.